Tumorigenicity of acridine orange.
作者信息
Van Duuren B L, Sivak A, Katz C, Melchionne S
出版信息
Br J Cancer. 1969 Sep;23(3):587-90. doi: 10.1038/bjc.1969.72.
Abstract
摘要
相似文献
1
Tumorigenicity of acridine orange.吖啶橙的致瘤性。
Br J Cancer. 1969 Sep;23(3):587-90. doi: 10.1038/bjc.1969.72.
2
3
Carcinogenicity of tetraethyl lead.四乙基铅的致癌性。
Experientia. 1968 Jun 15;24(6):580-1. doi: 10.1007/BF02153784.
4
Carcinogenic activity of 5-hydroxy-3,4-benzopyrene.
Gan. 1971 Oct;62(5):419-21.
5
6
The leukemogenic action of phorbol.佛波醇的致白血病作用。
Cancer Res. 1970 Nov;30(11):2744-8.
7
Strain differences in the response of rats to the injection of nickel sulphide.大鼠对注射硫化镍反应的品系差异
Br J Cancer. 1966 Dec;20(4):886-95. doi: 10.1038/bjc.1966.102.
8
Neoplasms in strains of splenectomized mice after a single 7,12-dimethylbenz[alpha]anthracene treatment.经单次7,12-二甲基苯并[a]蒽处理后脾切除小鼠品系中的肿瘤
J Natl Cancer Inst. 1975 Oct;55(4):893-7. doi: 10.1093/jnci/55.4.893.
9
Diffuse large B-cell lymphoma in a patient with rheumatoid arthritis treated with infliximab and methotrexate.一名类风湿关节炎患者在接受英夫利昔单抗和甲氨蝶呤治疗后发生弥漫性大B细胞淋巴瘤。
Clin Exp Dermatol. 2008 Jul;33(4):437-9. doi: 10.1111/j.1365-2230.2007.02683.x. Epub 2008 May 15.
10
Acridine orange.吖啶橙
IARC Monogr Eval Carcinog Risk Chem Man. 1978 Jan;16:145-52.
引用本文的文献
1
Acridine Orange: A Review of Novel Applications for Surgical Cancer Imaging and Therapy.吖啶橙：外科癌症成像与治疗新应用综述
Front Oncol. 2019 Sep 24;9:925. doi: 10.3389/fonc.2019.00925. eCollection 2019.
2
Natural extracellular nanovesicles and photodynamic molecules: is there a future for drug delivery?天然细胞外纳米囊泡与光动力分子：药物递送有未来吗？
J Enzyme Inhib Med Chem. 2017 Dec;32(1):908-916. doi: 10.1080/14756366.2017.1335310.
3
Interactions of histone, ribonuclease and acridine orange in enhancing film sarcoma.组蛋白、核糖核酸酶与吖啶橙在增强纤维肉瘤方面的相互作用。
Ir J Med Sci. 1983 Jul;152(7):272-5. doi: 10.1007/BF02954796.
4
Differences between drosophila melanogaster and its sibling species D. simulans in sensitivity to acridine orange treatment.黑腹果蝇及其近缘种拟果蝇在对吖啶橙处理的敏感性上的差异。
Experientia. 1983 Mar 15;39(3):300-1. doi: 10.1007/BF01955315.
5
Genetic mode of action of cocarcinogens and tumor promoters in yeast and mice.共致癌物和肿瘤促进剂在酵母和小鼠中的遗传作用模式。
Mol Gen Genet. 1984;194(1-2):7-14. doi: 10.1007/BF00383490.
6
Possible hazard in use of gentian violet.使用龙胆紫时可能存在的危害。
Br Med J. 1971 Sep 18;3(5776):702-3. doi: 10.1136/bmj.3.5776.702-d.
7
Miracil D: inhibition of deoxyribonucleic acid polymerase-deficient Escherichia coli.米拉西尔D：对缺乏脱氧核糖核酸聚合酶的大肠杆菌的抑制作用。
Antimicrob Agents Chemother. 1973 Apr;3(4):530-1. doi: 10.1128/AAC.3.4.530.
本文引用的文献
1
Mutagenesis of bacteriophage T4 by acridines.吖啶对噬菌体T4的诱变作用。
J Mol Biol. 1961 Dec;3:762-8. doi: 10.1016/s0022-2836(61)80081-8.
2
INFLUENCE OF MUTAGENS ON THE INITIATION OF SKIN CARCINOGENESIS.
Biochem Pharmacol. 1964 Feb;13:263-7. doi: 10.1016/0006-2952(64)90144-3.
3
Genetics of somatic mammalian cells. IV. Properties of Chinese hamster cell mutants with respect to the requirement for proline.哺乳动物体细胞遗传学。IV. 脯氨酸需求方面中国仓鼠细胞突变体的特性。
Genetics. 1967 Mar;55(3):513-24. doi: 10.1093/genetics/55.3.513.
4
Action of acridines on RNA and protein synthesis and on active transport in chick embryo cells.
Biochim Biophys Acta. 1966 Sep;123(3):585-95. doi: 10.1016/0005-2787(66)90225-5.
5
Testing chemicals for mutagenicity in a mammal.
Nature. 1966 Apr 9;210(5032):205-6. doi: 10.1038/210205a0.
6
The tumor-enhancing principles of Croton tiglium L.
Cancer Res. 1965 Dec;25(11):1871-5.
7
Carcinogenicity of epoxides, lactones, and peroxy compounds. II.环氧化物、内酯和过氧化物的致癌性。II.
J Natl Cancer Inst. 1965 Oct;35(4):707-17.
8
Inhibition of tumor induction in two-stage carcinogenesis on mouse skin.
Cancer Res. 1969 Apr;29(4):947-52.
9
Chemical mutagens in the human environment.人类环境中的化学诱变剂。
Nature. 1968 Jul 27;219(5152):385-7. doi: 10.1038/219385a0.
10
[Inhibition by acridines of genetic transfer by donor strains of Escherichia coli K 12].[吖啶对大肠杆菌K12供体菌株遗传转移的抑制作用]
Ann Inst Pasteur (Paris). 1966 Oct;111(4):427-36.
Zotero 插件